See the Presentations of the 13th ProEducar Fellows Course

  During SOLACI-SBHCI 2023, our traditional education program for young interventionists ProEducar Fellows Course was held.  Discover the presentations of the prestigious interventionists that made part of this 13th edition here below.  Dr. Gustavo Vignolo (UY) – “Trigger: STEMI learning clinical case” PRESENTATION Dr. Roger Renault Godinho (BRA) – “Why and how should I use Radial access? Step by Step” PRESENTATION<a href="https://solaci.org/en/2023/11/10/see-the-presentations-of-the-13th-proeducar-fellows-course/" title="Read more" >...</a>

By pass y actividad de la enfermedad en la arteria coronaria nativa

Long-Term Results from the BEST Study: Drug-Eluting Stents vs. Bypass Surgery in Diabetic Patients with Multiple Vessel Disease

The impact of diabetes on the development of cardiovascular disease is widely known, with a strong association with extensive and diffuse coronary artery disease. Decision-making regarding how to revascularize patients with multi-vessel disease is a complex process. In this context, coronary artery bypass grafting (CABG) has been recommended over percutaneous coronary intervention (PCI) based on<a href="https://solaci.org/en/2023/10/31/long-term-results-from-the-best-study-drug-eluting-stents-vs-bypass-surgery-in-diabetic-patients-with-multiple-vessel-disease/" title="Read more" >...</a>

TCT 2023 | T-PASS TRIAL, ASA and Ticagrelor in Acute Coronary Syndrome

This is a multicenter randomized study including 2,850 patients with acute coronary syndrome. Patients were randomized to: dual antiplatelet therapy (DAPT) with ASA and ticagrelor during one month (1,426 patients), followed by ticagrelor monotherapy for 12 months, while the other group received DAPT with ASA and ticagrelor during 12 months (1,424 patients). This study was<a href="https://solaci.org/en/2023/10/30/tct-2023-t-pass-trial-asa-and-ticagrelor-in-acute-coronary-syndrome/" title="Read more" >...</a>

Complex Coronary Angioplasty in Elderly Patients: Problem or Solution?

Cardiovascular disease is the leading cause of death in elderly adults (individuals aged 75 years or older). In turn, coronary heart disease is one of the main causes of morbidity in this population. In addition to anatomical complexities, there are other factors that may complicate its management, such as polypharmacy, frailty, and procedure-related risks. All of<a href="https://solaci.org/en/2023/10/18/complex-coronary-angioplasty-in-elderly-patients-problem-or-solution/" title="Read more" >...</a>

Resonancia vs FFR en lesiones no culpables del infarto

Cardiac Angiography: Necessary for CABG Patient Diagnosis?

Cardiac revascularization surgery (CABG) has shown positive results at long term in CAD patients with multivessel or left main disease. However, we are well aware that, after CABG, there might be native disease progression over time. Also, at followup, we often see high incidence of venous graft failure.  According to registry data, approximately 1 in<a href="https://solaci.org/en/2023/10/12/cardiac-angiography-necessary-for-cabg-patient-diagnosis/" title="Read more" >...</a>

Nueva y discrepante información sobre los vasos no culpables en el infarto

Prognostic Impact of SYNTAX and SYNTAX II Scores in Patients with Acute Myocardial Infarction

Acute myocardial infarction (AMI) continues to be a clinically significant condition due to its association with morbidity and mortality after the initial event. Therefore, the prognostic stratification of these patients is of vital importance. One of the tools that have been used for several years for this purpose is the SYNTAX I (SS) and SYNTAX<a href="https://solaci.org/en/2023/09/25/prognostic-impact-of-syntax-and-syntax-ii-scores-in-patients-with-acute-myocardial-infarction/" title="Read more" >...</a>

La cirugía parece superior a la angioplastia en pacientes jóvenes

ISCHEMIA Trial: Does Complete Anatomical or Functional Revascularization Modify Anything Compared with Medical Treatment?

Chronic coronary syndrome (CCS) has been considered another comorbidity in previous studies, and there has been no significant reduction in cardiovascular mortality or myocardial infarction (MI) rates with revascularization through percutaneous coronary intervention (PCI) or myocardial revascularization surgery (MRS) compared with optimal medical treatment (OMT). One possible reason for the lack of benefit has been<a href="https://solaci.org/en/2023/09/21/ischemia-trial-does-complete-anatomical-or-functional-revascularization-modify-anything-compared-with-medical-treatment/" title="Read more" >...</a>

Fentanilo en la angioplatia: ¿Cuál es el precio de un mayor confort en el procedimiento?

Substudy TALOS AMI: from Ticagrelor to Clopidogrel in Patients with High Risk of Bleeding and AMI

The preference for the use of potent P2Y12 inhibitors such as ticagrelor and prasugrel in patients with high risk of acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) is based on randomized studies and current guideline recommendations. However, clopidogrel is still recommended for patients at high risk of bleeding. Several strategies have been looked<a href="https://solaci.org/en/2023/09/20/substudy-talos-ami-from-ticagrelor-to-clopidogrel-in-patients-with-high-risk-of-bleeding-and-ami/" title="Read more" >...</a>

Is Complete Revascularization Really Necessary after AMI in the Elderly?

The population over 75 is growing gradually, which entails an increase in acute myocardial infarction (AMI) in this group. As we all know, it is fairly common for AMI to present with multivessel disease.  It has been shown that younger patients will benefit from complete revascularization vs. a simple resolution of the culprit vessel. However,<a href="https://solaci.org/en/2023/09/13/is-complete-revascularization-really-necessary-after-ami-in-the-elderly/" title="Read more" >...</a>

Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

TAVI-in-TAVI with Balloon-Expandable Valves

TAVI (Transcatheter Aortic Valve Implantation) has proven to be beneficial and is currently performed in increasingly younger and lower-risk patients. However, as with surgical bioprostheses, structural deterioration, whether due to stenosis or regurgitation, is one of the challenges we must address.  While currently uncommon, this is an issue we will probably see more and more<a href="https://solaci.org/en/2023/09/12/tavi-in-tavi-with-balloon-expandable-valves/" title="Read more" >...</a>